150 related articles for article (PubMed ID: 21142661)
1. Evaluation of current and upcoming therapies in oral mucositis prevention.
Wu JC; Beale KK; Ma JD
Future Oncol; 2010 Nov; 6(11):1751-70. PubMed ID: 21142661
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data.
Quinn B
Eur J Cancer Care (Engl); 2013 Sep; 22(5):564-79. PubMed ID: 23731197
[TBL] [Abstract][Full Text] [Related]
3. Mucositis: current management and investigations.
Garden AS
Semin Radiat Oncol; 2003 Jul; 13(3):267-73. PubMed ID: 12903015
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
Demarosi F; Bez C; Carrassi A
Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy: the effect of oral cryotherapy on the development of mucositis.
Karagözoğlu S; Filiz Ulusoy M
J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284
[TBL] [Abstract][Full Text] [Related]
6. Oral mucositis: time for more studies.
Alvarado Y; Bellm LA; Giles FJ
Hematology; 2002 Oct; 7(5):281-9. PubMed ID: 12850815
[TBL] [Abstract][Full Text] [Related]
7. NCCN Task Force Report. prevention and management of mucositis in cancer care.
Bensinger W; Schubert M; Ang KK; Brizel D; Brown E; Eilers JG; Elting L; Mittal BB; Schattner MA; Spielberger R; Treister NS; Trotti AM
J Natl Compr Canc Netw; 2008 Jan; 6 Suppl 1():S1-21; quiz S22-4. PubMed ID: 18289497
[TBL] [Abstract][Full Text] [Related]
8. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer.
Naidu MU; Ramana GV; Rani PU; Mohan IK; Suman A; Roy P
Neoplasia; 2004; 6(5):423-31. PubMed ID: 15548350
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies.
Sorensen JB; Skovsgaard T; Bork E; Damstrup L; Ingeberg S
Cancer; 2008 Apr; 112(7):1600-6. PubMed ID: 18300265
[TBL] [Abstract][Full Text] [Related]
11. Management of oral mucositis in patients with cancer.
Stone R; Fliedner MC; Smiet AC
Eur J Oncol Nurs; 2005; 9 Suppl 1():S24-32. PubMed ID: 16202654
[TBL] [Abstract][Full Text] [Related]
12. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
13. Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience.
Rzepecki P; Sarosiek T; Barzal J; Oborska S; Nurzynski P; Wasko A; Szczylik C
J BUON; 2007; 12(4):477-82. PubMed ID: 18067205
[TBL] [Abstract][Full Text] [Related]
14. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of oral mucositis.
Silverman S
J Support Oncol; 2007 Feb; 5(2 Suppl 1):13-21. PubMed ID: 17366929
[TBL] [Abstract][Full Text] [Related]
16. Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice.
Peterson DE; Keefe DM; Hutchins RD; Schubert MM
Support Care Cancer; 2006 Jun; 14(6):499-504. PubMed ID: 16775646
[TBL] [Abstract][Full Text] [Related]
17. Cancer treatment-induced oral mucositis.
Alterio D; Jereczek-Fossa BA; Fiore MR; Piperno G; Ansarin M; Orecchia R
Anticancer Res; 2007; 27(2):1105-25. PubMed ID: 17465250
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
Sonis ST; Elting LS; Keefe D; Peterson DE; Schubert M; Hauer-Jensen M; Bekele BN; Raber-Durlacher J; Donnelly JP; Rubenstein EB; ;
Cancer; 2004 May; 100(9 Suppl):1995-2025. PubMed ID: 15108222
[TBL] [Abstract][Full Text] [Related]
19. Palifermin for patients with haematological malignancies: shifting nursing practice from symptom relief to prevention of oral mucositis.
Fliedner M; Baguet B; Blankart J; Davies M; Henriques E; Leather A; Mazur E; Mihály K; Peeters L; Radványiné A; Sedlackova B
Eur J Oncol Nurs; 2007; 11 Suppl 1():S19-26. PubMed ID: 17540295
[TBL] [Abstract][Full Text] [Related]
20. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
Le QT; Kim HE; Schneider CJ; Muraközy G; Skladowski K; Reinisch S; Chen Y; Hickey M; Mo M; Chen MG; Berger D; Lizambri R; Henke M
J Clin Oncol; 2011 Jul; 29(20):2808-14. PubMed ID: 21670453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
